×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [11]
内容类型
期刊论文 [11]
发表日期
2018 [4]
2017 [2]
2016 [1]
2015 [1]
2014 [1]
2013 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia
期刊论文
2018, 卷号: 7, 期号: 2, 页码: IJH06
作者:
Ma Jun
;
Liu Ting
;
Jin Jie
;
Hu Jianda
;
Liu Qifa
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
ALL
China
Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia
acute lymphoblastic leukemia
chemotherapy
relapsed/refractory
retrospective observational study
Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning
期刊论文
2018, 卷号: 9, 期号: 1, 页码: 524-538
作者:
Guo, Zhi
;
Xu, Chen
;
Chen, Hu
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/03
reduce intensity
allogeneic hematopoietic stem cell transplantation
ETO positive
acute myeloid leukemia
relapsed
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus
期刊论文
2018, 卷号: 97, 期号: 11, 页码: 2047-2054
作者:
Long, Zhangbiao
;
Yu, Fan
;
Du, Yali
;
Li, Hongmin
;
Chen, Miao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Acquired pure red cell aplasia
Refractory
relapsed
Cyclosporine A
Sirolimus
Regulatory T cells
Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, DoubleBlind Phase 2 Trial
期刊论文
2018, 卷号: 13, 期号: 10, 页码: S351-S352
作者:
Cheng, Y.
;
Wang, Q.
;
Li, K.
;
Shi, J.
;
Wu, L.
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Anlotinib
3rd line
relapsed SCLC
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study
期刊论文
2017, 卷号: 10, 期号: 1, 页码: 137
作者:
Hou, Jian
;
Jin, Jie
;
Xu, Yan
;
Wu, Depei
;
Ke, Xiaoyan
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/04
China
Ixazomib
Multiple myeloma
Oral
Overall survival
Progression-free survival
Proteasome inhibitor
Relapsed/refractory
Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review
期刊论文
2017, 卷号: 17, 页码: 87-91
作者:
Xue Jingwen
;
Liu Cynthia
;
Liu Yuehua
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Photodynamic therapy
Relapsed or refractory mycosis fungoides
Aminolevulinic acid
Methyl aminolevulinic acid
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
期刊论文
2016, 卷号: 35, 期号: 1, 页码: 86
作者:
Leng, Yun
;
Qiu, Lugui
;
Hou, Jian
;
Zhao, Yaozhong
;
Zhang, Xuejun
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/04
Recombinant human circularly permuted TRAIL
Phase II trial
Relapsed or refractory multiple myeloma
Efficacy
Safety
Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome
期刊论文
2015, 卷号: 95, 期号: 4, 页码: 325-330
作者:
Cai, Qian-Qian
;
Wang, Chen
;
Cao, Xin-Xin
;
Cai, Hao
;
Zhou, Dao-Bin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
POEMS syndrome
lenalidomide
relapsed or refractory
vascular endothelial growth factor
Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma
期刊论文
2014, 卷号: 5, 期号: 17, 页码: 7368-7380
作者:
Cai, Qingqing
;
Chen, Yiming
;
Zou, Dehui
;
Zhang, Liang
;
Badillo, Maria
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
Clinical outcomes
Lenalidomide
Relapsed lymphoma
Rituximab
Stem cell transplantation
Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer
期刊论文
2013, 卷号: 4, 期号: 4, 页码: 440-448
作者:
Sun, Yan
;
Wang, Jin Wan
;
Liu, Yong Yu
;
Yu, Qi Tao
;
Zhang, Yi Ping
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
Advanced and relapsed NSCLC
angiogenesis inhibitor
Endostar
NP regimen
recombinant human endostatin
survival benefit
©版权所有 ©2017 CSpace - Powered by
CSpace